These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5053336)

  • 1. [Results of use of solcoseryl in the complex treatment of dystrophic disorders in obliterating arterial diseases of the extremities].
    Vishnevskiĭ AA; Zolotarevskiĭ VIa; Savchenko TV; Sergel' OS; Platonov ND
    Eksp Khir Anesteziol; 1972; 17(1):43-8. PubMed ID: 5053336
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 3. [Arterial diseases of the lower limbs. Treatment with anticoagulants. Value of their long-term use].
    Jouve A; Pierron J; Avril P; Nakache A
    Nouv Presse Med; 1972 Sep; 1(34):2250-2. PubMed ID: 4628245
    [No Abstract]   [Full Text] [Related]  

  • 4. [The position of low molecular weight plasma expanders in the treatment of obliterative angio-organopathies: influence of Infukoll-M 40 on the circulation of the extremities and hemodynamics of the kidney].
    Hackel F
    Dtsch Gesundheitsw; 1971 Apr; 26(17):771-8. PubMed ID: 5576719
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
    Myers KA
    Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of xavin in vascular diseases of the lower extremities].
    Volgin EG
    Klin Med (Mosk); 1980 Oct; 58(10):46-50. PubMed ID: 7442096
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conservative treatment of arterial peripheral blood circulation disorders].
    Bollinger A
    Schweiz Rundsch Med Prax; 1971 Aug; 60(32):1071-4. PubMed ID: 5565228
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with bencyclane in peripheral disorders of arterial blood supply].
    Alánt O; Horváth N
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1403+. PubMed ID: 5536654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of arterial insufficiency in the lower extremities].
    Sevelsted H; Oram V
    Ugeskr Laeger; 1971 Apr; 133(17):803-4. PubMed ID: 4930839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic tactics in pregangrenous phase of obliterating diseases of arteries of the extremities].
    Krakovskiĭ NI
    Sov Med; 1973 Oct; 36(10):7-12. PubMed ID: 4789219
    [No Abstract]   [Full Text] [Related]  

  • 13. [On conserative treatment of arterial circulation disorders].
    Hänel W
    Ther Ggw; 1968 Apr; 107(4):546-8. PubMed ID: 5672326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience in the use of pyrogenal in the treatment of vascular diseases of the lower extremities].
    Kargin VD; Klimova KN; Damsker IS
    Sov Med; 1968 Apr; 31(4):19-23. PubMed ID: 5669768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Application of bencyclane in arterial insufficiency of the lower limbs].
    Krylov VS; Zuravlev IV; Djacenko GM; Vychovskaja AA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1433+. PubMed ID: 5536664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Factors influencing the disability of patients with obliterating diseases of the arteries of the lower extremities].
    Il'chenko VIa
    Vrach Delo; 1972 Sep; 9():39-43. PubMed ID: 4658115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles and results of clinical therapeutic courses of chronic arterial obstruction diseases of lower extremities].
    Sohr C
    Dtsch Gesundheitsw; 1970 Oct; 25(42):1969-75. PubMed ID: 5517208
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of thromboelastography in obliterating diseases of the arteries of the extremities].
    Barkagan ZS; Chernenko VF
    Khirurgiia (Mosk); 1969 Jun; 45(6):60-5. PubMed ID: 5344796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of treatment of degenerative arterial diseases of the lower extremities with intravenous administration of magnesium compositum Scharffenberg and hyaluronidase].
    Grosshennig F
    Dtsch Gesundheitsw; 1966 May; 21(19):869-72. PubMed ID: 5973759
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical treatment of arterial disorders of the extremities.
    Abramson DI
    Mod Treat; 1967 Mar; 4(2):350-69. PubMed ID: 5341884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.